Invention Grant
- Patent Title: Use of interleukin 17E for the treatment of cancer
- Patent Title (中): 使用白介素17E治疗癌症
-
Application No.: US11817914Application Date: 2006-03-08
-
Publication No.: US08287851B2Publication Date: 2012-10-16
- Inventor: Jim A. Wright , Aiping H. Young , Yoon Lee , Ming Yu Cao
- Applicant: Jim A. Wright , Aiping H. Young , Yoon Lee , Ming Yu Cao
- Applicant Address: CA Toronto
- Assignee: Lorus Therapeutics Inc.
- Current Assignee: Lorus Therapeutics Inc.
- Current Assignee Address: CA Toronto
- Agency: Bozicevic, Field & Francis LLP
- Agent Carol L. Francis
- International Application: PCT/CA2006/000311 WO 20060308
- International Announcement: WO2006/094384 WO 20060914
- Main IPC: A61K38/20
- IPC: A61K38/20
Abstract:
The use of interleukin 17E to inhibit tumor growth in a subject is provided. The interleukin 17E can be provided to the subject exogenously, as an interleukin 17E polypeptide or a polynucleotide encoding an interleukin 17E polypeptide, or it can be provided by stimulating production of endogenous interleukin 17E. Also provided is the use of interleukin 17E in combination with one or more anti-cancer therapeutics for inhibiting tumor growth in a subject. Anti-cancer therapeutics include, for example, standard chemotherapeutic drugs, immunotherapeutics, radiation, gene therapy, hormone manipulation and antisense therapy.
Public/Granted literature
- US20110158936A1 USE OF INTERLEUKIN 17E FOR THE TREATMENT OF CANCER Public/Granted day:2011-06-30
Information query
IPC分类:
